PRECLINICAL STUDIES OF PORFIROMYCIN AS AN ADJUNCT TO RADIOTHERAPY

被引:63
作者
ROCKWELL, S [1 ]
KEYES, SR [1 ]
SARTORELLI, AC [1 ]
机构
[1] YALE UNIV,SCH MED,CTR COMPREHENS CANC,DEPT PHARMACOL,NEW HAVEN,CT 06510
关键词
D O I
10.2307/3577481
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:100 / 113
页数:14
相关论文
共 35 条
[1]  
BAKER L H, 1976, Medical and Pediatric Oncology, V2, P207, DOI 10.1002/mpo.2950020211
[2]  
CARTER SK, 1968, CANCER CHEMOTH REP 3, V1, P81
[4]   EXPLOITATION OF OXYGEN ENHANCEMENT RATIO IN CLINICAL PRACTICE [J].
DUNCAN, W .
BRITISH MEDICAL BULLETIN, 1973, 29 (01) :33-38
[5]  
FOWLER J F, 1983, Radiotherapy and Oncology, V1, P1, DOI 10.1016/S0167-8140(83)80003-6
[6]  
GAMBAVITALO C, 1983, EXP HEMATOL, V11, P382
[7]  
HAHN GM, 1974, CANCER RES, V34, P351
[8]   THE CELLULAR BASIS OF LONG-TERM MARROW INJURY AFTER IRRADIATION [J].
HENDRY, JH .
RADIOTHERAPY AND ONCOLOGY, 1985, 3 (04) :331-338
[9]   MITOMYCIN-C AND PORFIROMYCIN ANALOGS WITH SUBSTITUTED ETHYLAMINES AT POSITION-7 [J].
IYENGAR, BS ;
SAMI, SM ;
REMERS, WA ;
BRADNER, WT ;
SCHURIG, JE .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (01) :16-20
[10]   HYPOXIC TUMOR-CELL - TARGET FOR SELECTIVE CANCER-CHEMOTHERAPY [J].
KENNEDY, KA ;
TEICHER, BA ;
ROCKWELL, S ;
SARTORELLI, AC .
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (01) :1-8